Tivity Health, Inc. (TVTY) Tops Q3 EPS by 10c, Slight Miss on Revenues; Boosts FY17 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tivity Health (TVTY) PT Raised to $51 at Jefferies Following 3Q
October 27, 2017 8:48 AM EDTJefferies raised its price target on Tivity Health (NASDAQ: TVTY) to $51.00 (from $46.00) while maintaining a Buy rating following 3Q earnings report. The strong 3Q results and 2017 guidance raise have TVTY growing revenue 11% this year and expanding EBITDA margins to 22.8%.
The strong momentum should give... More
